SARS-CoV-2 Spike Trimer Protein (G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N), His Tag (MALS verified)

产品评论
货号-规格
价格
Qty.
SPN-C52Hs-50ug
¥4725.00
SPN-C52Hs-500ug
¥29400.00
Fiber-add-1piece
可选服务
询价
合计0件 产品金额¥ 0

产品信息

分子别名(Synonym)

Spike,S protein,Spike glycoprotein,S glycoprotein

表达区间及表达系统(Source)

SARS-CoV-2 Spike Trimer, His Tag (SPN-C52Hs) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). Mutations G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N were identified in the SARS-CoV-2 Lambda variant (Pango lineage: C.37). The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively.

Predicted N-terminus: Val 16

Request for sequence

蛋白结构(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 137.3 kDa. The protein migrates as 160-200 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in 0.1 M Sodium citrate, pH5.5 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

产品数据图

 

电泳(SDS-PAGE)

Spike protein SDS-PAGE

SARS-CoV-2 Spike Trimer, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS

Spike protein SEC-MALS

The purity of SARS-CoV-2 Spike Trimer, His Tag (Cat. No. SPN-C52Hs) is more than 90% and the molecular weight of this protein is around 510-575 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-ELISA

Spike protein ELISA

Immobilized SARS-CoV-2 Spike Trimer, His Tag (Cat. No. SPN-C52Hs) at 1 μg/mL (100 μL/well) can bind Human ACE2, Fc Tag (Cat. No. AC2-H5257) with a linear range of 0.1-6 ng/mL (QC tested).

Protocol

Spike protein ELISA

Immobilized SARS-CoV-2 Spike Trimer, His Tag (Cat. No. SPN-C52Hs) at 1 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (Cat. No. S1N-M122) with a linear range of 0.1-3 ng/mL (Routinely tested).

Protocol

Spike protein ELISA

Immobilized Human ACE2, Fc Tag (Cat. No. AC2-H5257) at 5 μg/mL (100 μL/well) can bind SARS-CoV-2 Spike Trimer, His Tag (Cat. No. SPN-C52Hs) with a linear range of 0.2-16 ng/mL (Routinely tested).

Protocol

Spike protein ELISA

Immobilized Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (Cat. No. S1N-M122) at 1 μg/mL (100 μL/well) can bind SARS-CoV-2 Spike Trimer, His Tag (Cat. No. SPN-C52Hs) with a linear range of 0.1-6 ng/mL (Routinely tested).

Protocol

 

产品评论
发表评论

背景

It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

前沿进展

 
靶点信息
  • 英文全称:

    Coronavirus spike glycoprotein

  • 中文全称:

    冠状病毒刺突糖蛋白

  • 种类:

  • 上市药物数量:

    9 详情

  • 临床药物数量:

    71 详情

  • 最高研发阶段:

    批准上市

数据表和文档
联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品信息
  • 产品数据图
  • 产品评论
  • 背景